Corrigendum to "Low leptin but high insulin resistance of smokers in Japanese men" [Diabetes Res. Clin. Pract. 81 (2008) 358-364] (DOI:10.1016/j.diabres.2008.05.005);Low leptin but high insulin resistance of smokers in Japanese men

Diabetes Research and Clinical Practice

Volumn 81, Issue 3, 2008, Pages 358-364

  Hotta, Yo ^a   Yatsuya, Hiroshi ^a   Toyoshima, Hideaki ^a,b   Matsushita, Kunihiro ^a   Mitsuhashi, Hirotsugu ^a   Takefuji, Seiko ^a   Oiso, Yutaka ^a   Tamakoshi, Koji ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b ANJO KOSEI HOSPITAL   (Japan)

Author keywords

Cross sectional study; Diabetes; HOMA IR; Leptin; Smoking

Indexed keywords

INSULIN; LEPTIN;

ADULT; AGED; ANAMNESIS; ARTICLE; BODY MASS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; HOMEOSTASIS; HORMONE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; JAPAN; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; QUESTIONNAIRE; SMOKING;

EID: 48949086573     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2008.09.035     Document Type: Erratum

References (49)

1. Zhang Y., Proenca R., Maffei M., Barone M., Leopold L., and Friedman J.M. Positional cloning of the mouse obese gene and its human homologue. Nature 372 (1994) 425-432
2. Tartaglia L.A., Dembski M., Weng X., Deng N., Culpepper J., Devos R., et al. Identification and expression cloning of a leptin receptor, OB-R. Cell 83 (1995) 1263-1271
3. Campfield L.A., Smith F.J., and Burn P. The OB protein (leptin) pathway-a link between adipose tissue mass and central neural networks. Horm. Metab. Res. 28 (1996) 619-632
4. Boden G., Chen X., Kolaczynski J.W., and Polansky M. Effects of prolonged hyperinsulinemia on serum leptin in normal human subjects. J. Clin. Invest. 100 (1997) 1107-1113
5. Yildiz B.O., and Haznedaroglu I.C. Rethinking leptin and insulin action: therapeutic opportunities for diabetes. Int. J. Biochem. Cell. Biol. 38 (2006) 820-830
6. McNeely M.J., Boyko E.J., Weigle D.S., Shofer J.B., Chessler S.D., Leonnetti D.L., et al. Association between baseline plasma leptin levels and subsequent development of diabetes in Japanese Americans. Diabetes Care 22 (1999) 65-70
7. Franks P.W., Brage S., Luan J., Ekelund U., Rahman M., Farooqi I.S., et al. Leptin predicts a worsening of the features of the metabolic syndrome independently of obesity. Obes. Res. 13 (2005) 1476-1484
8. Unger R.H. Minireview: weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome. Endocrinology 144 (2003) 5159-5165
9. Haque W.A., Shimomura I., Matsuzawa Y., and Garg A. Serum adiponectin and leptin levels in patients with lipodystrophies. J. Clin. Endocrinol. Metab. 87 (2002) 2395
10. Halaas J.L., Gajiwala K.S., Maffei M., Cohen S.L., Cheit B.T., Rabinowitz D., et al. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 269 (1995) 543-546
11. Considine R.V., Sinha M.K., Heiman M.L., Kriauciunas A., Stephens T.W., Nyce M.R., et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N. Engl. J. Med. 334 (1996) 292-295
12. Oral E.A., Simha V., Ruiz E., Andewelt A., Premkumar A., Snell P., et al. Leptin-replacement therapy for lipodystrophy. N. Engl. J. Med. 346 (2002) 570-578
13. Attvall S., Fowelin J., Lager I., Von Schenck H., and Smith U. Smoking induces insulin resistance-a potential link with the insulin resistance syndrome. J. Intern. Med. 233 (1993) 327-332
14. Facchini F.S., Hollenbeck C.B., Jeppesen J., Chen Y.D., and Reaven G.M. Insulin resistance and cigarette smoking. Lancet 339 (1992) 1128-1130
15. Schmidt M.I., Duncan B.B., Vigo A., Pankow J.S., Couper D., Ballantyne C.M., et al. Leptin and incident type 2 diabetes: risk or protection?. Diabetologia 49 (2006) 2086-2096
16. Yatsuya H., Tamakoshi K., Hattori H., Otsuka R., Wada K., Zhang H., et al. Serum phospholipid transfer protein mass as a possible protective factor for coronary heart diseases. Circ. J. 68 (2004) 11-16
17. Mabuchi T., Yatsuya H., Tamakoshi K., Otsuka R., Nagasawa N., Zhang H., et al. Association between serum leptin concentration and white blood cell count in middle-aged Japanese men and women. Diabetes Metab. Res. Rev. 21 (2005) 441-447
18. Chobanian A.V., Bakris G.L., Black H.R., Cushman W.C., Green L.A., Izzo Jr. J.L., et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 289 (2003) 2560-2572
19. Lee J. Covariance adjustment of rates based on the multiple logistic regression model. J. Chronic Dis. 34 (1981) 415-426
20. Allison P.D. Logistic Regression Using the SAS System: Theory and Application (1999), SAS Institute Inc., Cary, NC
21. Frati A.C., Iniestra F., and Ariza C.R. Acute effect of cigarette smoking on glucose tolerance and other cardiovascular risk factors. Diabetes Care 19 (1996) 112-118
22. Manson J.E., Ajani U.A., Liu S., Nathan D.M., and Hennekens C.H. A prospective study of cigarette smoking and the incidence of diabetes mellitus among US male physicians. Am. J. Med. 109 (2000) 538-542
23. Foy C.G., Bell R.A., Farmer D.F., Goff Jr. D.C., and Wagenknecht L.E. Smoking and incidence of diabetes among U.S. adults: findings from the Insulin Resistance Atherosclerosis Study. Diabetes Care 28 (2005) 2501-2507
24. Hodge A.M., Westerman R.A., de Courten M.P., Collier G.R., Zimmet P.Z., and Alberti K.G. Is leptin sensitivity the link between smoking cessation and weight gain?. Int. J. Obes. Relat. Metab. Disord. 21 (1997) 50-53
25. Donahue R.P., Zimmet P., Bean J.A., Decourten M., DeCarlo Donahue R.A., Collier G., et al. Cigarette smoking, alcohol use, and physical activity in relation to serum leptin levels in a multiethnic population: The Miami Community Health Study. Ann. Epidemiol. 9 (1999) 108-113
26. Wei M., Stern M.P., and Haffner S.M. Serum leptin levels in Mexican Americans and non-Hispanic whites: association with body mass index and cigarette smoking. Ann. Epidemiol. 7 (1997) 81-86
27. Ruige J.B., Dekker J.M., Blum W.F., Stehouwer C.D., Nijpels G., Mooy J., et al. Leptin and variables of body adiposity, energy balance, and insulin resistance in a population-based study, The Hoorn Study. Diabetes Care 22 (1999) 1097-1104
28. Reseland J.E., Mundal H.H., Hollung K., Haugen F., Zahid N., Anderssen S.A., et al. Cigarette smoking may reduce plasma leptin concentration via catecholamines. Prostaglandins Leukot. Essent Fatty Acids 73 (2005) 43-49
29. Billimoria J.D., Pozner H., Metselaar B., Best F.W., and James D.C. Effect of cigarette smoking on lipids, lipoproteins, blood coagulation, fibrinolysis and cellular components of human blood. Atherosclerosis 21 (1975) 61-76
30. Stamford B.A., Matter S., Fell R.D., Sady S., Papanek P., and Cresanta M. Cigarette smoking, exercise and high density lipoprotein cholesterol. Atherosclerosis 52 (1975) 73-83
31. Lee Y., Wang M.Y., Kakuma T., Wang Z.W., Babcock E., McCorkle K., et al. Liporegulation in diet-induced obesity. The antisteatotic role of hyperleptinemia. J. Biol. Chem. 276 (2001) 5629-5635
32. Shimabukuro M., Koyama K., Chen G., Wang M.Y., Trieu F., Lee Y., et al. Direct antidiabetic effect of leptin through triglyceride depletion of tissues. Proc. Natl. Acad. Sci. USA 94 (1997) 4637-4641
33. Harris R.B. Acute and chronic effects of leptin on glucose utilization in lean mice. Biochem. Biophys. Res. Commun. 245 (1998) 502-509
34. Rossetti L., Massillon D., Barzilai N., Vuguin P., Chen W., Hawkins M., et al. Short term effects of leptin on hepatic gluconeogenesis and in vivo insulin action. J. Biol. Chem. 272 (1997) 27758-27763
35. Liu L., Karkanias G.B., Morales J.C., Hawkins M., Barzilai N., Wang J., et al. Intracerebroventricular leptin regulates hepatic but not peripheral glucose flexes. J. Biol. Chem. 273 (1998) 31160-31167
36. Zhang Y., and Scarpace P.J. The role of leptin in leptin resistance and obesity. Physiol. Behav. 88 (2006) 249-256
37. Shimomura I., Hammer R.E., Ikemoto S., Brown M.S., and Goldstein J.L. Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy. Nature 401 (1999) 73-76
38. Shimabukuro M., Wang M.Y., Zhou Y.T., Newgard C.B., and Unger R.H. Protection against lipoapoptosis of beta cells through leptin-dependent maintenance of Bcl-2 expression. Proc. Natl. Acad. Sci. USA 95 (1998) 9558-9561
39. Toyoshima Y., Gavrilova O., Yakar S., Jou W., Pack S., Asghar Z., et al. Leptin improves insulin resistance and hyperglycemia in a mouse model of type 2 diabetes. Endocrinology 146 (2005) 4024-4035
40. Cryer P.E., Haymond M.W., Santiago J.V., and Shah S.D. Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events. N. Engl. J. Med. 295 (1976) 573-577
41. Mark A.L., Rahmouni K., Correia M., and Haynes W.G. A leptin-sympathetic-leptin feedback loop: potential implications for regulation of arterial pressure and body fat. Acta Physiol. Scand. 177 (2003) 345-349
42. Eliasson B., and Smith U. Leptin levels in smokers and long-term users of nicotine gum. Eur. J. Clin. Invest. 29 (1999) 145-152
43. Bamia C., Trichopoulou A., Lenas D., and Trichopoulos D. Tobacco smoking in relation to body fat mass and distribution in a general population sample. Int. J. Obes. Relat. Metab. Disord. 28 (2004) 1091-1096
44. Shimokata H., Muller D.C., and Andres R. Studies in the distribution of body fat. III. Effects of cigarette smoking. JAMA 261 (1989) 1169-1173
45. Park K.G., Park K.S., Kim M.J., Kim H.S., Suh Y.S., Ahn J.D., et al. Relationship between serum adiponectin and leptin concentrations and body fat distribution. Diabetes Res. Clin. Pract. 63 (2004) 135-142
46. Zhang W.Z., Venardos K., Chin-Dusting J., and Kaye D.M. Adverse effects of cigarette smoke on NO bioavailability: role of arginine metabolism and oxidative stress. Hypertension 48 (2006) 278-285
47. Kamigaki M., Sakaue S., Tsujino I.S.O.##H., Ikeda D., Itoh N., et al. Oxidative stress provokes atherogenic changes in adipokine gene expression in 3T3-L1 adipocytes. Biochem. Biophys. Res. Commun. 339 (2006) 624-632
48. Stern N., Osher E., and Greenman Y. Hypoadiponectinemia as a marker of adipocyte dysfunction. Part I. The biology of adiponectin. J. Cardiometab. Syndr. 2 (2007) 174-182
49. Bennet A.M., Brismar K., Hallqvist J., Reuterwall C., and De Faire U. The risk of myocardial infarction is enhanced by a synergistic interaction between serum insulin and smoking. Eur. J. Endocrinol. 147 (2002) 641-647